Jacobson S H, Lu Y, Brauner A
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Nephrol Dial Transplant. 1996 Nov;11(11):2209-14. doi: 10.1093/oxfordjournals.ndt.a027138.
Urinary tract infections activate both mucosal and systemic inflammatory responses reflected by elevation of cytokine concentrations in serum and urine. We determined urine and serum concentrations of tumour necrosis factor soluble receptors I and II (sTNFR I and sTNFR II) and interleukin-1 receptor antagonist (IL-1ra) in 41 women with acute pyelonephritis caused by Escherichia coli, 2 weeks after the infection, during a subsequent episode of cystitis or asymptomatic bacteriuria and also later when the same patients were free from bacteriuria. Concentrations of sTNFR I, sTNFR II and IL-1ra were related to the expression of five virulence markers of E. coli, glomerular filtration rate (GFR) and to the concentration of C-reactive protein (CRP) in serum. Patients with acute pyelonephritis had elevated serum concentrations of sTNFR I and sTNFR II compared to healthy women (P < 0.001 for both comparisons). The concentrations of sTNFR I and sTNFR II in urine were significantly higher in patients with acute pyelonephritis compared to controls (P < 0.001 in both cases). The concentration of sTNFR II in urine was higher in patients infected by E. coli producing haemolysin (P = 0.05) and in patients infected by E. coli expressing hydrophobic properties (P = 0.05) compared to patients infected by strains without these virulence traits. Patients who had high concentrations of sTNFR II in serum during acute pyelonephritis had lower GFR at follow-up (r = -0.48, P = 0.05). Patients who responded with a marked increase in CRP had higher sTNFR I and sTNFR II in urine (r = 0.58, P < 0.01 and r = 0.48, P < 0.01, respectively). The concentrations of sTNFR I and sTNFR II in serum and urine decreased during follow-up and were lower 2 weeks after the infection when all patients were free from bacteriuria. IL-1ra in serum was elevated during pyelonephritis (P < 0.001) while that in urine was significantly lower compared to controls (P < 0.001). It is concluded that the increased concentrations of TNF receptors may block the cytotoxic and inflammatory actions and reduce the sensibility of renal cells to TNF alpha-mediated effects.
尿路感染会激活黏膜和全身炎症反应,这可通过血清和尿液中细胞因子浓度的升高反映出来。我们测定了41例由大肠杆菌引起的急性肾盂肾炎女性患者在感染后2周、随后膀胱炎发作期或无症状菌尿期以及之后无细菌尿时尿液和血清中肿瘤坏死因子可溶性受体I和II(sTNFR I和sTNFR II)以及白细胞介素-1受体拮抗剂(IL-1ra)的浓度。sTNFR I、sTNFR II和IL-1ra的浓度与大肠杆菌的五种毒力标志物的表达、肾小球滤过率(GFR)以及血清中C反应蛋白(CRP)的浓度相关。与健康女性相比,急性肾盂肾炎患者血清中sTNFR I和sTNFR II的浓度升高(两种比较均P < 0.001)。与对照组相比,急性肾盂肾炎患者尿液中sTNFR I和sTNFR II的浓度显著更高(两种情况均P < 0.001)。与感染无这些毒力特征菌株的患者相比,感染产生溶血素的大肠杆菌的患者尿液中sTNFR II的浓度更高(P = 0.05),感染具有疏水性的大肠杆菌的患者尿液中sTNFR II的浓度更高(P = 0.05)。急性肾盂肾炎期间血清中sTNFR II浓度高的患者在随访时GFR较低(r = -0.48,P = 0.05)。CRP显著升高的患者尿液中sTNFR I和sTNFR II更高(分别为r = 0.58,P < 0.01和r = 0.48,P < 0.01)。随访期间血清和尿液中sTNFR I和sTNFR II的浓度降低,在感染后2周所有患者无细菌尿时更低。肾盂肾炎期间血清中IL-1ra升高(P < 0.001),而尿液中的IL-1ra与对照组相比显著更低(P < 0.001)。结论是,TNF受体浓度的升高可能会阻断细胞毒性和炎症作用,并降低肾细胞对TNFα介导作用的敏感性。